Pharmacological Therapy in Children with Atrial Fibrillation and Atrial Flutter

Author(s): Giovanni Fazio, Claudia Visconti, Luciana D'Angelo, Giuseppina Novo, Giuseppe Barbaro, Salvatore Novo

Journal Name: Current Pharmaceutical Design

Volume 14 , Issue 8 , 2008

Become EABM
Become Reviewer
Call for Editor


Heart rhythm disorders in children are not different, on electrocardiographic trace, from heart rhythm disorders in adults with the exception of incidence which is different according to the age. Paticularly, atrial flutter (FlA) and fibrillation (FA) are very uncommon arrhythmias in the general pediatric population. Generally atrial fibrillation and atrial flutter, in our experience, is a temporary heart rhythm disturbance connected to specifical and resovable reasons with the exception of Fontains surgical correction of congenital heart diseases or cardiopathies with dilatation of both atria. Presenting symptoms, symptom history (e.g., frequency, duration, and severity), risk assessment, previous response to alternative treatment options, convenience and patient preference for a specific treatment option, and costeffectiveness of a treatment option are among the many factors that should be considered. Treatment of atrial flutter and fibrillation in pediatric age involves several options: Pharmacological therapy, Transoesophageal atrial pacing (TEAP), Electrical cardioversion and Catheter ablation. In this review we evaluated the physiopathology, the clinical features and the current terapeutical strategies for these arrythmias in paediatric age.

Keywords: Atrial fibrillation, atrial flutter, children, treatment

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [770 - 775]
Pages: 6
DOI: 10.2174/138161208784007707
Price: $65

Article Metrics

PDF: 17